Protagenic Therapeutics, Inc.\new (PTIX) SEC Filings & Financial Intelligence
Protagenic Therapeutics, Inc.\new (PTIX) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PTIX
CIK: 1022899
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
GreenGrowth CPAs
Auditor SinceSince 3/31/2025 12:00:00 AM
Lead Engagement PartnerMauro Botta
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-24 | 2026-08-21 | 4 | 0001493152-26-039816 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-20 | 4 | 0001493152-26-039537 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | 8-K | 0001493152-26-039410 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | 4 | 0001493152-26-039399 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001493152-26-039221 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038256 | View SEC Doc Filr Page |
| 10-K | 2026-08-14 | 2026-03-31 | 10-K | 0001493152-26-038255 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-11 | 4 | 0001493152-26-037468 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 | 0001493152-26-036782 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-05 | 4 | 0001493152-26-036442 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 | 0001493152-26-035868 | View SEC Doc Filr Page |
| NT 10-K | 2026-06-30 | 2026-03-31 | NT 10-K | 0001493152-26-031235 | View SEC Doc Filr Page |
| 8-K | 2026-04-07 | 2026-03-31 | 8-K | 0001493152-26-015365 | View SEC Doc Filr Page |
| 10-Q | 2026-03-09 | 2025-12-31 | 10-Q | 0001493152-26-009301 | View SEC Doc Filr Page |
| 8-K | 2026-03-03 | 2026-02-03 | 8-K | 0001493152-26-008605 | View SEC Doc Filr Page |
| 8-K | 2026-02-24 | 2026-02-17 | 8-K | 0001493152-26-007800 | View SEC Doc Filr Page |
| NT 10-Q | 2026-02-18 | 2025-12-31 | NT 10-Q | 0001493152-26-007254 | View SEC Doc Filr Page |
| 25-NSE | 2026-01-23 | — | 25-NSE Filing | 0001354457-26-000085 | View SEC Doc Filr Page |
| 8-K | 2026-01-05 | 2025-12-31 | 8-K | 0001493152-26-000263 | View SEC Doc Filr Page |
| DEF 14A | 2025-12-05 | 2025-12-05 | DEF 14A | 0001493152-25-026414 | View SEC Doc Filr Page |
| 10-Q | 2025-11-26 | 2025-09-30 | 10-Q | 0001493152-25-025201 | View SEC Doc Filr Page |
| 8-K | 2025-11-26 | 2025-11-20 | 8-K | 0001493152-25-025159 | View SEC Doc Filr Page |
| NT 10-Q | 2025-11-14 | 2025-09-30 | NT 10-Q | 0001493152-25-023624 | View SEC Doc Filr Page |
| 8-K | 2025-11-05 | 2025-11-03 | 8-K | 0001493152-25-020881 | View SEC Doc Filr Page |
| 8-K | 2025-10-31 | 2025-10-28 | 8-K | 0001493152-25-020444 | View SEC Doc Filr Page |